Home›People›Claudio Rumazza
CR

Claudio Rumazza

Director at SymKardia and executive officer and director at Nocionix

ExecutiveDirectorRoles at 2 startups
Updated Nov 6, 2026·Latest SEC filing Nov 4, 2026·Suggest an edit

About Claudio Rumazza

Claudio Rumazza is a director of SymKardia, a company working to treat cardiac arrhythmias with selective cardiac neuromodulation. He is also an executive officer and director of Nocionix.

Experience

This experience comes from SEC filings. The years are when the filings name Claudio Rumazza in the role, so the role may have started earlier or lasted longer.

Nocionix,Inc.
Executive officer and director
2026 · Westlake, OH
Nocionix develops a nerve-based therapy for people with chronic pain that avoids hormones, surgery, and opioids.
SymKardia, Inc.
Director
2026 · Westlake, OH
SymKardia is developing selective cardiac neuromodulation as a new way to treat patients with cardiac arrhythmias.

Key Colleagues at Startups

The people Claudio Rumazza works with at each company, as listed on that company's latest Form D.

Nocionix,Inc. · Form D, Nov 4, 2026
RP
AS
Arun Sridhar
Director
AC
Anthony Caparso
President and director
JB
TA
Tony Artiga
Director
SymKardia, Inc. · Form D/A, Oct 28, 2026
AC
Anthony Caparso
President and director
Bruce KenKnight
Bruce KenKnight
Chief Executive Officer
Steven Girouard
Steven Girouard
Executive officer
Jonathan Piccini
Jonathan Piccini
Executive officer
Imad Libbus
Imad Libbus
Chief Scientific Officer
Dwight Skinner
Dwight Skinner
Executive officer
RP
AS
Arun Sridhar
Director
JB

Sources

  1. SECNocionix,Inc. Form D, filed Nov 4, 2026
  2. SECSymKardia, Inc. Form D/A, filed Oct 28, 2026
  3. companySymKardia website